img

Global Arthritis Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Arthritis Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includesPsoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Arthritis Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Arthritis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Retail Pharmacies and Hospital Pharmacies are the major drivers for the industry.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Arthritis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
Segment by Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics

Segment by Application


Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Arthritis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Arthritis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Arthritis Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Arthritis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Arthritis Drug introduction, etc. Arthritis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Arthritis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Arthritis Drug Market Overview
1.1 Arthritis Drug Product Overview
1.2 Arthritis Drug Market Segment by Type
1.2.1 Synthetic DMARDs
1.2.2 Biological DMARDs
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.2.5 Analgesics
1.3 Global Arthritis Drug Market Size by Type
1.3.1 Global Arthritis Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Arthritis Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Arthritis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Arthritis Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Arthritis Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Arthritis Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Arthritis Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Arthritis Drug Sales Breakdown by Type (2024-2024)
2 Global Arthritis Drug Market Competition by Company
2.1 Global Top Players by Arthritis Drug Sales (2024-2024)
2.2 Global Top Players by Arthritis Drug Revenue (2024-2024)
2.3 Global Top Players by Arthritis Drug Price (2024-2024)
2.4 Global Top Manufacturers Arthritis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Arthritis Drug Market Competitive Situation and Trends
2.5.1 Arthritis Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Arthritis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Arthritis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Arthritis Drug Market
2.8 Key Manufacturers Arthritis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Arthritis Drug Status and Outlook by Region
3.1 Global Arthritis Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Arthritis Drug Historic Market Size by Region
3.2.1 Global Arthritis Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Arthritis Drug Sales in Value by Region (2024-2024)
3.2.3 Global Arthritis Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Arthritis Drug Forecasted Market Size by Region
3.3.1 Global Arthritis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Arthritis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Arthritis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Arthritis Drug by Application
4.1 Arthritis Drug Market Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Drug Stores
4.1.4 E-Commerce
4.2 Global Arthritis Drug Market Size by Application
4.2.1 Global Arthritis Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Arthritis Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Arthritis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Arthritis Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Arthritis Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Arthritis Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Arthritis Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Arthritis Drug Sales Breakdown by Application (2024-2024)
5 North America Arthritis Drug by Country
5.1 North America Arthritis Drug Historic Market Size by Country
5.1.1 North America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Arthritis Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Arthritis Drug Sales in Value by Country (2024-2024)
5.2 North America Arthritis Drug Forecasted Market Size by Country
5.2.1 North America Arthritis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Arthritis Drug Sales in Value by Country (2024-2034)
6 Europe Arthritis Drug by Country
6.1 Europe Arthritis Drug Historic Market Size by Country
6.1.1 Europe Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Arthritis Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Arthritis Drug Sales in Value by Country (2024-2024)
6.2 Europe Arthritis Drug Forecasted Market Size by Country
6.2.1 Europe Arthritis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Arthritis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Arthritis Drug by Region
7.1 Asia-Pacific Arthritis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Arthritis Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Arthritis Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Arthritis Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Arthritis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Arthritis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Arthritis Drug Sales in Value by Region (2024-2034)
8 Latin America Arthritis Drug by Country
8.1 Latin America Arthritis Drug Historic Market Size by Country
8.1.1 Latin America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Arthritis Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Arthritis Drug Sales in Value by Country (2024-2024)
8.2 Latin America Arthritis Drug Forecasted Market Size by Country
8.2.1 Latin America Arthritis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Arthritis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Arthritis Drug by Country
9.1 Middle East and Africa Arthritis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Arthritis Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Arthritis Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Arthritis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Arthritis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Arthritis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Novartis Arthritis Drug Products Offered
10.1.5 Novartis Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Eli Lilly Arthritis Drug Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Celltrion
10.3.1 Celltrion Company Information
10.3.2 Celltrion Introduction and Business Overview
10.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Celltrion Arthritis Drug Products Offered
10.3.5 Celltrion Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 F. Hoffmann-La Roche Arthritis Drug Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Arthritis Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Johnson & Johnson Arthritis Drug Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 GSK
10.7.1 GSK Company Information
10.7.2 GSK Introduction and Business Overview
10.7.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 GSK Arthritis Drug Products Offered
10.7.5 GSK Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Arthritis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Arthritis Drug Industrial Chain Analysis
11.4 Arthritis Drug Market Dynamics
11.4.1 Arthritis Drug Industry Trends
11.4.2 Arthritis Drug Market Drivers
11.4.3 Arthritis Drug Market Challenges
11.4.4 Arthritis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Arthritis Drug Distributors
12.3 Arthritis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Synthetic DMARDs
Table 2. Major Company of Biological DMARDs
Table 3. Major Company of NSAIDs
Table 4. Major Company of Corticosteroids
Table 5. Major Company of Analgesics
Table 6. Global Arthritis Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Arthritis Drug Sales by Type (2024-2024) & (K Units)
Table 8. Global Arthritis Drug Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Arthritis Drug Sales by Type (2024-2024) & (US& Million)
Table 10. Global Arthritis Drug Market Share in Value by Type (2024-2024)
Table 11. Global Arthritis Drug Price by Type (2024-2024) & (USD/Unit)
Table 12. Global Arthritis Drug Sales by Type (2024-2034) & (K Units)
Table 13. Global Arthritis Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Arthritis Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Arthritis Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Arthritis Drug Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Arthritis Drug Sales by Type (2024-2024) & (K Units)
Table 18. North America Arthritis Drug Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Arthritis Drug Sales (K Units) by Type (2024-2024)
Table 20. Europe Arthritis Drug Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Arthritis Drug Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Arthritis Drug Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Arthritis Drug Sales (K Units) by Type (2024-2024)
Table 24. Latin America Arthritis Drug Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Arthritis Drug Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Arthritis Drug Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Arthritis Drug Sales by Company (2024-2024) & (K Units)
Table 28. Global Arthritis Drug Sales Share by Company (2024-2024)
Table 29. Global Arthritis Drug Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Arthritis Drug Revenue Share by Company (2024-2024)
Table 31. Global Market Arthritis Drug Price by Company (2024-2024) & (USD/Unit)
Table 32. Global Arthritis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Arthritis Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Arthritis Drug Market
Table 36. Key Manufacturers Arthritis Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Arthritis Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Arthritis Drug Sales by Region (2024-2024) & (K Units)
Table 40. Global Arthritis Drug Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Arthritis Drug Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Arthritis Drug Sales Market Share in Value by Region (2024-2024)
Table 43. Global Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 44. Global Arthritis Drug Sales by Region (2024-2034) & (K Units)
Table 45. Global Arthritis Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Arthritis Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Arthritis Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Arthritis Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Arthritis Drug Sales by Application (2024-2024) & (K Units)
Table 51. Global Arthritis Drug Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Arthritis Drug Sales Market Share in Value by Application (2024-2024)
Table 54. Global Arthritis Drug Price by Application (2024-2024) & (USD/Unit)
Table 55. Global Arthritis Drug Sales by Application (2024-2034) & (K Units)
Table 56. Global Arthritis Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Arthritis Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Arthritis Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Arthritis Drug Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Arthritis Drug Sales by Application (2024-2024) (K Units)
Table 61. North America Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Arthritis Drug Sales by Application (2024-2024) (K Units)
Table 63. Europe Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Arthritis Drug Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Arthritis Drug Sales by Application (2024-2024) (K Units)
Table 67. Latin America Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Arthritis Drug Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Arthritis Drug Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Arthritis Drug Sales by Country (2024-2024) & (K Units)
Table 71. North America Arthritis Drug Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Arthritis Drug Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Arthritis Drug Sales Market Share in Value by Country (2024-2024)
Table 74. North America Arthritis Drug Sales by Country (2024-2034) & (K Units)
Table 75. North America Arthritis Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Arthritis Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Arthritis Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Arthritis Drug Sales by Country (2024-2024) & (K Units)
Table 79. Europe Arthritis Drug Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Arthritis Drug Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Arthritis Drug Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Arthritis Drug Sales by Country (2024-2034) & (K Units)
Table 83. Europe Arthritis Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Arthritis Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Arthritis Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Arthritis Drug Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Arthritis Drug Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Arthritis Drug Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Arthritis Drug Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Arthritis Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Arthritis Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Arthritis Drug Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Arthritis Drug Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Arthritis Drug Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Arthritis Drug Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Arthritis Drug Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Arthritis Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Arthritis Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Arthritis Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Arthritis Drug Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Arthritis Drug Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Arthritis Drug Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Arthritis Drug Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Arthritis Drug Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Arthritis Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Arthritis Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Arthritis Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Novartis Company Information
Table 111. Novartis Introduction and Business Overview
Table 112. Novartis Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 113. Novartis Arthritis Drug Product
Table 114. Novartis Recent Development
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Introduction and Business Overview
Table 117. Eli Lilly Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 118. Eli Lilly Arthritis Drug Product
Table 119. Eli Lilly Recent Development
Table 120. Celltrion Company Information
Table 121. Celltrion Introduction and Business Overview
Table 122. Celltrion Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 123. Celltrion Arthritis Drug Product
Table 124. Celltrion Recent Development
Table 125. F. Hoffmann-La Roche Company Information
Table 126. F. Hoffmann-La Roche Introduction and Business Overview
Table 127. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 128. F. Hoffmann-La Roche Arthritis Drug Product
Table 129. F. Hoffmann-La Roche Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Introduction and Business Overview
Table 132. Pfizer Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 133. Pfizer Arthritis Drug Product
Table 134. Pfizer Recent Development
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Introduction and Business Overview
Table 137. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 138. Johnson & Johnson Arthritis Drug Product
Table 139. Johnson & Johnson Recent Development
Table 140. GSK Company Information
Table 141. GSK Introduction and Business Overview
Table 142. GSK Arthritis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 143. GSK Arthritis Drug Product
Table 144. GSK Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Arthritis Drug Market Trends
Table 148. Arthritis Drug Market Drivers
Table 149. Arthritis Drug Market Challenges
Table 150. Arthritis Drug Market Restraints
Table 151. Arthritis Drug Distributors List
Table 152. Arthritis Drug Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Arthritis Drug Product Picture
Figure 2. Global Arthritis Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Arthritis Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Arthritis Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Synthetic DMARDs
Figure 6. Global Synthetic DMARDs Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Biological DMARDs
Figure 8. Global Biological DMARDs Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of NSAIDs
Figure 10. Global NSAIDs Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Corticosteroids
Figure 12. Global Corticosteroids Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Analgesics
Figure 14. Global Analgesics Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Arthritis Drug Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Arthritis Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Arthritis Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Arthritis Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Arthritis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Arthritis Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Arthritis Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Arthritis Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Arthritis Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Arthritis Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Arthritis Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Arthritis Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Arthritis Drug Revenue in 2022
Figure 29. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Hospital Pharmacies
Figure 33. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Drug Stores
Figure 35. Global Drug Stores Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of E-Commerce
Figure 37. Global E-Commerce Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Arthritis Drug Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Arthritis Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America Arthritis Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Arthritis Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Arthritis Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Arthritis Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Arthritis Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Arthritis Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Arthritis Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Arthritis Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Arthritis Drug Manufacturing Cost Structure
Figure 51. Arthritis Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries